Literature DB >> 34120510

Maximizing the Efficiency of Active Case Finding for SARS-CoV-2 Using Bandit Algorithms.

Gregg S Gonsalves1,2, J Tyler Copple1,2, A David Paltiel3,2, Eli P Fenichel4, Jude Bayham5, Mark Abraham6, David Kline7, Sam Malloy8, Michael F Rayo9, Net Zhang8, Daria Faulkner10, Dane A Morey9, Frank Wu1,2, Thomas Thornhill1,2, Suzan Iloglu1,2, Joshua L Warren11.   

Abstract

Even as vaccination for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) expands in the United States, cases will linger among unvaccinated individuals for at least the next year, allowing the spread of the coronavirus to continue in communities across the country. Detecting these infections, particularly asymptomatic ones, is critical to stemming further transmission of the virus in the months ahead. This will require active surveillance efforts in which these undetected cases are proactively sought out rather than waiting for individuals to present to testing sites for diagnosis. However, finding these pockets of asymptomatic cases (i.e., hotspots) is akin to searching for needles in a haystack as choosing where and when to test within communities is hampered by a lack of epidemiological information to guide decision makers' allocation of these resources. Making sequential decisions with partial information is a classic problem in decision science, the explore v. exploit dilemma. Using methods-bandit algorithms-similar to those used to search for other kinds of lost or hidden objects, from downed aircraft or underground oil deposits, we can address the explore v. exploit tradeoff facing active surveillance efforts and optimize the deployment of mobile testing resources to maximize the yield of new SARS-CoV-2 diagnoses. These bandit algorithms can be implemented easily as a guide to active case finding for SARS-CoV-2. A simple Thompson sampling algorithm and an extension of it to integrate spatial correlation in the data are now embedded in a fully functional prototype of a web app to allow policymakers to use either of these algorithms to target SARS-CoV-2 testing. In this instance, potential testing locations were identified by using mobility data from UberMedia to target high-frequency venues in Columbus, Ohio, as part of a planned feasibility study of the algorithms in the field. However, it is easily adaptable to other jurisdictions, requiring only a set of candidate test locations with point-to-point distances between all locations, whether or not mobility data are integrated into decision making in choosing places to test.

Entities:  

Keywords:  SARS-CoV-2; bandit algorithms; reinforcement learning; surveillance; testing

Mesh:

Year:  2021        PMID: 34120510      PMCID: PMC8484027          DOI: 10.1177/0272989X211021603

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.749


  18 in total

1.  The Holy Grail: The search for undiagnosed cases is paramount in improving the cascade of care among people living with HIV.

Authors:  Oghenowede Eyawo; Robert S Hogg; Julio S G Montaner
Journal:  Can J Public Health       Date:  2013-09-27

Review 2.  Toward an endgame: finding and engaging people unaware of their HIV-1 infection in treatment and prevention.

Authors:  David N Burns; Victor DeGruttola; Christopher D Pilcher; Mirjam Kretzschmar; Christopher M Gordon; Elizabeth H Flanagan; Christopher Duncombe; Myron S Cohen
Journal:  AIDS Res Hum Retroviruses       Date:  2014-02-11       Impact factor: 2.205

3.  A novel time-limited pop-up HIV testing service for gay men in Sydney, Australia, attracts high-risk men.

Authors:  Vickie Knight; Marianne Gale; Rebecca Guy; Nicolas Parkhill; Jo Holden; Craig Leeman; Anna McNulty; Phillip Keen; Handan Wand
Journal:  Sex Health       Date:  2014-09       Impact factor: 2.706

4.  Seroprevalence of SARS-CoV-2 Antibodies in the US Adult Asymptomatic Population as of September 30, 2020.

Authors:  Robert L Stout; Steven J Rigatti
Journal:  JAMA Netw Open       Date:  2021-03-01

Review 5.  Diagnostics for SARS-CoV-2 infections.

Authors:  Bhavesh D Kevadiya; Jatin Machhi; Jonathan Herskovitz; Maxim D Oleynikov; Wilson R Blomberg; Neha Bajwa; Dhruvkumar Soni; Srijanee Das; Mahmudul Hasan; Milankumar Patel; Ahmed M Senan; Santhi Gorantla; JoEllyn McMillan; Benson Edagwa; Robert Eisenberg; Channabasavaiah B Gurumurthy; St Patrick M Reid; Chamindie Punyadeera; Linda Chang; Howard E Gendelman
Journal:  Nat Mater       Date:  2021-02-15       Impact factor: 47.656

6.  The coronavirus is here to stay - here's what that means.

Authors:  Nicky Phillips
Journal:  Nature       Date:  2021-02       Impact factor: 69.504

Review 7.  Active case finding with case management: the key to tackling the COVID-19 pandemic.

Authors:  Zhongjie Li; Qiulan Chen; Luzhao Feng; Lance Rodewald; Yinyin Xia; Hailiang Yu; Ruochen Zhang; Zhijie An; Wenwu Yin; Wei Chen; Ying Qin; Zhibin Peng; Ting Zhang; Daxin Ni; Jinzhao Cui; Qing Wang; Xiaokun Yang; Muli Zhang; Xiang Ren; Dan Wu; Xiaojin Sun; Yuanqiu Li; Lei Zhou; Xiaopeng Qi; Tie Song; George F Gao; Zijian Feng
Journal:  Lancet       Date:  2020-06-04       Impact factor: 79.321

8.  Field performance and public health response using the BinaxNOW TM Rapid SARS-CoV-2 antigen detection assay during community-based testing.

Authors:  Genay Pilarowski; Carina Marquez; Luis Rubio; James Peng; Jackie Martinez; Douglas Black; Gabriel Chamie; Diane Jones; Jon Jacobo; Valerie Tulier-Laiwa; Susana Rojas; Susy Rojas; Chesa Cox; Maya Petersen; Joe DeRisi; Diane V Havlir
Journal:  Clin Infect Dis       Date:  2020-12-26       Impact factor: 9.079

9.  Why Contact Tracing Efforts Have Failed to Curb Coronavirus Disease 2019 (COVID-19) Transmission in Much of the United States.

Authors:  Eva Clark; Elizabeth Y Chiao; E Susan Amirian
Journal:  Clin Infect Dis       Date:  2021-05-04       Impact factor: 9.079

10.  What do the Universal Test and Treat trials tell us about the path to HIV epidemic control?

Authors:  Diane Havlir; Shahin Lockman; Helen Ayles; Joseph Larmarange; Gabriel Chamie; Tendani Gaolathe; Collins Iwuji; Sarah Fidler; Moses Kamya; Sian Floyd; Janet Moore; Richard Hayes; Maya Petersen; Francois Dabis
Journal:  J Int AIDS Soc       Date:  2020-02       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.